Abstract:Introduction: Herpes zoster is caused by the reactivation of latent varicella infection within the sensory ganglia, caused by the varicella-zoster virus (VZV). The disease is classically characterized by a painful unilateral vesicular eruption. Complications of the disease include herpes zoster ophthalmicus, Ramsay Hunt syndrome, acute retinal necrosis, and post-herpetic neuralgia. In this paper, we discuss the epidemiology, pathogenesis, clinical features, diagnosis, management, and vaccination strategies of herpes zoster and post-herpetic neuralgia. Method: This paper was developed with input from specialists from Singapore's public sectors—dermatologists, family physicians, and infectious diseases specialists. Results: The diagnosis of herpes zoster is clinical and can be aided with laboratory investigations. Early initiation of antivirals, within 72 h of onset, can reduce the severity and duration of the condition and decrease the intensity of pain. In patients with a high risk of post-herpetic neuralgia, early initiation of anticonvulsants or tricyclic antidepressants can be considered. Herpes zoster is highly preventable, with the advent of the recombinant zoster vaccine (RZV) providing an overall vaccine efficacy of 97.2%. Procedures such as epidural blocks and subcutaneous or intracutaneous injections of local anesthetics and steroids can be considered for patients with a high risk of post-herpetic neuralgia to reduce its incidence. Conclusion: This article serves as a guideline for clinicians in the diagnosis, investigations, management, and prevention of herpes zoster. With the majority of adults in Singapore currently at risk of developing herpes zoster due to varicella immunization being only introduced in 2020, it is important for clinicians to recognize and manage herpes zoster appropriately.

Herpes zoster triggered by ChAdOx1 nCoV-19 coronavirus vaccine (recombinant)

Herpes Zoster Reactivation After mRNA and Adenovirus-Vectored Coronavirus Disease 2019 Vaccination: Analysis of National Health Insurance Database

Herpes Zoster Following COVID-19 Vaccination in an Immunocompetent and Vaccinated for Herpes Zoster Adult: A Two-Vaccine Related Event?

Acute Pancreatitis Associated with Herpes Zoster: Case Report and Literature Review.

Herpes zoster Reactivation After COVID-19 Vaccine with Focus on Postherpetic Neuralgia Prevention: A Case Series

Kaposi Sarcoma as a Possible Cutaneous Adverse Effect of ChAdOx1 nCov-19 Vaccine: A Case Report

Varicella Zoster Virus Reactivation Following COVID-19 Vaccination: A Systematic Review of Case Reports

A Case Report of Herpes Zoster Ophthalmicus and Meningitis After COVID-19 Vaccination

Deep vein thrombosis and acute hepatitis after ChAdOx1 nCov-19 vaccination in a Charcot-Marie-Tooth patient: a case report

Haemophagocytic lymphohistiocytosis post-ChAdOx1 nCoV-19 vaccine: A rare case

Oral Herpes Zoster Following Anti-Covid-19 Vaccination: Is There A Relationship?.

Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2

Varicella-zoster virus reactivation causing herpes zoster ophthalmicus (HZO) after SARS-CoV-2 vaccination – report of three cases

The risk of postherpetic neuralgia in COVID-19 vaccination-associated herpes zoster: A retrospective cohort study using TriNetX

Herpes Zoster in a Patient with Ulcerative Colitis after Vedolizumab Initiation-Causal Link or Only Temporal Coincidence?

Herpes Zoster and Post-Herpetic Neuralgia—Diagnosis, Treatment, and Vaccination Strategies

Herpes Zoster Eruption in an Otherwise Healthy Child: A Case Report

The Impact of the COVID-19 Pandemic on the Incidence of Herpes Zoster: A Narrative Literature Review

Orocutaneous Opportunistic Infections In Vaccinated Patient For Sars-Cov-2: A Case Report.

Herpes zoster ophthalmicus following recombinant zoster vaccine: A case report and brief literature review

ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review